LABORATORIOS FARMACEUTICOS ROVI, S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.3 EUR | +1.93% |
|
+6.10% | +40.03% |
| Apr. 02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
| Mar. 12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 85.00 | 85.00 | 85.00 |
| Spread/Res. | -0.82% | -0.82% | -0.82% |
| Spread/Supp. | +3.31% | +37.86% | +48.55% |
| Support | 81.60 | 61.15 | 56.75 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ROVI Stock
- Charts Laboratorios Farmaceuticos Rovi, S.A.
